157 related articles for article (PubMed ID: 18437592)
1. DBBF modified human placenta hemoglobin through the alpha chains.
Huang L; Wang B; Wang X; Liang WG; Yang CM
Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(2):156-65. PubMed ID: 18437592
[TBL] [Abstract][Full Text] [Related]
2. PEG and DBBF modified porcine hemoglobin and their oxygen-carrying capacity.
Hong M; Cai J; Meng WF; Li SY; Yuan ZY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jul; 34(4):452-6. PubMed ID: 12098767
[TBL] [Abstract][Full Text] [Related]
3. Chemically modified porcine hemoglobins and their biological properties.
Jin C; Wen-Fang M; Min H; Pei-Lin C; Zhong-Yi Y
Protein Pept Lett; 2004 Aug; 11(4):353-60. PubMed ID: 15327368
[TBL] [Abstract][Full Text] [Related]
4. Modification of hemoglobin - tetrameric stabilization.
Tye RW; Medina F; Bolin RB; Knopp GL; Irion GS; McLaughlin SK
Prog Clin Biol Res; 1983; 122():41-9. PubMed ID: 6878380
[TBL] [Abstract][Full Text] [Related]
5. A method for purification and viral inactivation of human placenta hemoglobin.
Li T; Yu R; Zhang HH; Wang H; Liang WG; Yang XM; Yang CM
Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(2):175-88. PubMed ID: 16537173
[TBL] [Abstract][Full Text] [Related]
6. Reaction of human hemoglobin HbA0 and two cross-linked derivatives with hydrogen peroxide: differential behavior of the ferryl intermediate.
Cashon RE; Alayash AI
Arch Biochem Biophys; 1995 Jan; 316(1):461-9. PubMed ID: 7840650
[TBL] [Abstract][Full Text] [Related]
7. Effects of polymerization on the oxygen carrying and redox properties of diaspirin cross-linked hemoglobin.
Rogers MS; Ryan BB; Cashon RE; Alayash AI
Biochim Biophys Acta; 1995 Apr; 1248(2):135-42. PubMed ID: 7748895
[TBL] [Abstract][Full Text] [Related]
8. Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats.
Abassi Z; Kotob S; Pieruzzi F; Abouassali M; Keiser HR; Fratantoni JC; Alayash AI
J Lab Clin Med; 1997 Jun; 129(6):603-10. PubMed ID: 9178726
[TBL] [Abstract][Full Text] [Related]
9. Redox concerns in the use of acellular hemoglobin-based therapeutic oxygen carriers: the role of plasma components.
Harrington JP; Gonzalez Y; Hirsch RE
Artif Cells Blood Substit Immobil Biotechnol; 2000 Nov; 28(6):477-92. PubMed ID: 11063090
[TBL] [Abstract][Full Text] [Related]
10. Differential susceptibilities of the prosthetic heme of hemoglobin-based red cell substitutes. Implications in the design of safer agents.
Osawa Y; Darbyshire JF; Meyer CA; Alayash AI
Biochem Pharmacol; 1993 Dec; 46(12):2299-305. PubMed ID: 8274164
[TBL] [Abstract][Full Text] [Related]
11. Comparison of effects of two hemoglobin-based O(2) carriers on intestinal integrity and microvascular leakage.
Baldwin AL; Wiley EB; Alayash AI
Am J Physiol Heart Circ Physiol; 2002 Oct; 283(4):H1292-301. PubMed ID: 12234778
[TBL] [Abstract][Full Text] [Related]
12. Sodium selenite reduces hemoglobin-induced venular leakage in the rat mesentery.
Baldwin AL; Wiley EB; Summers AG; Alayash AI
Am J Physiol Heart Circ Physiol; 2003 Jan; 284(1):H81-91. PubMed ID: 12388216
[TBL] [Abstract][Full Text] [Related]
13. Acellular hemoglobin-mediated oxidative stress toward endothelium: a role for ferryl iron.
Goldman DW; Breyer RJ; Yeh D; Brockner-Ryan BA; Alayash AI
Am J Physiol; 1998 Sep; 275(3):H1046-53. PubMed ID: 9724312
[TBL] [Abstract][Full Text] [Related]
14. Chemical characterization of diaspirin cross-linked hemoglobin polymerized with poly(ethylene glycol).
Buehler PW; Boykins RA; Norris S; Alayash AI
Anal Chem; 2006 Jul; 78(13):4634-41. PubMed ID: 16808476
[TBL] [Abstract][Full Text] [Related]
15. Infusion of stroma-free cross-linked hemoglobin during acute gram-negative bacteremia.
Crowley JP; Metzger J; Gray A; Pivacek LE; Cassidy G; Valeri CR
Circ Shock; 1993 Nov; 41(3):144-9. PubMed ID: 8269643
[TBL] [Abstract][Full Text] [Related]
16. Purification and viral inactivation of hemoglobin from human placenta blood.
Li F; Zhang H; Wang J; Yang C
Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(2):57-60. PubMed ID: 19229697
[TBL] [Abstract][Full Text] [Related]
17. Effects of (-)-epigallocatechin gallate on the redox reactions of human hemoglobin.
Jia Y; Alayash AI
Free Radic Biol Med; 2008 Sep; 45(5):659-66. PubMed ID: 18539156
[TBL] [Abstract][Full Text] [Related]
18. Morphologic effects of hypervolemic administration of DBBF hemoglobin in the rat.
Clifford CB; Wessels DA; Smith CD
Biomater Artif Cells Artif Organs; 1990; 18(2):321-8. PubMed ID: 2369654
[TBL] [Abstract][Full Text] [Related]
19. Intravascular circulation and distribution of human 51Cr-DBBF stroma-free hemoglobin, 51Cr-plasma, 51Cr-saline, 59FE-plasma, and 125I-albumin in the mouse.
Valeri CR; Ichikura T; Pivacek LE; Giorgio A; Prusty S; Dittmer J
Artif Cells Blood Substit Immobil Biotechnol; 2000 Nov; 28(6):451-75. PubMed ID: 11063089
[TBL] [Abstract][Full Text] [Related]
20. Site-specific modifications and toxicity of blood substitutes. The case of diaspirin cross-linked hemoglobin.
D'Agnillo F; Alayash AI
Adv Drug Deliv Rev; 2000 Feb; 40(3):199-212. PubMed ID: 10837790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
